Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Policy

    Policy - Page 48

    GST will benefit healthcare sector: CII

    GST will benefit healthcare sector: CII

    Ruby Khatun Khatun2 July 2017 9:38 AM IST
    New Delhi: The Goods and Services Tax (GST) will benefit the healthcare sector and promote local manufacturing, industry body CII.The GST, India's...
    Delhi High Court to hear pharma firms plea on fixed dose drugs ban

    Delhi High Court to hear pharma firms plea on fixed dose drugs ban

    Ruby Khatun Khatun30 Jun 2017 11:44 AM IST
    The Delhi High Court will today hear the plea filed by several pharmaceutical companies that sought a stay of a central government notification that...
    DoP accepts Sun Pharmas review petition on Fucibet cream 15 gm AI tube while rejecting Histac EVT 2’s AI strip

    DoP accepts Sun Pharma's review petition on Fucibet cream 15 gm AI tube while rejecting Histac EVT 2’s AI strip

    Ruby Khatun Khatun29 Jun 2017 9:57 AM IST
    The Department of Pharmaceuticals (DoP) has accepted Sun Pharmaceutical's review petition against price fixation of “Fucibet cream 15 gm AI tube” and...
    GST Trauma: Chemist Drop medicine storage, Temporary Shortage Likely

    GST Trauma: Chemist Drop medicine storage, Temporary Shortage Likely

    Meghna A Singhania26 Jun 2017 12:04 PM IST
    New Delhi: Uncertain about the impact of GST on their business, chemists across the country, seem to be turning down fresh inventories ahead of its...
    Vaccines can be blamed for illnesses without proof, holds EU top court

    Vaccines can be blamed for illnesses without proof, holds EU top court

    Ruby Khatun Khatun24 Jun 2017 11:19 AM IST
    London: The highest court of the European Union ruled that courts can consider whether a vaccination led to someone developing an illness even when...
    Government of India bans Gemifloxacin, Ambroxol combination

    Government of India bans Gemifloxacin, Ambroxol combination

    Ruby Khatun Khatun22 Jun 2017 10:20 AM IST
    Department of Health and Family Welfare of Ministry of Health and Family Welfare, Government of India has banned fixed dose combinations Gemifloxacin...
    NPPA to set ceiling prices exclusive of GST rates

    NPPA to set ceiling prices exclusive of GST rates

    Ruby Khatun Khatun22 Jun 2017 9:22 AM IST
    NPPA in its 46th meeting held on 0.3 6.2017 has decided to notify ceiling prices of Scheduled formulations exclusive of applicable GST rates, after...
    FDA approves new antibiotic, Baxdela to treat serious skin infections

    FDA approves new antibiotic, Baxdela to treat serious skin infections

    Ruby Khatun Khatun21 Jun 2017 12:39 PM IST
    The U.S. Food and Drug Administration on Monday approved a new treatment for patients with acute bacterial skin infections, made by privately held...
    Narendra Modi pays maiden visit to CDRI, 3 new drugs to be introduced

    Narendra Modi pays maiden visit to CDRI, 3 new drugs to be introduced

    Ruby Khatun Khatun21 Jun 2017 11:19 AM IST
    Lucknow:Prime Minister Narendra Modi recently visited the premier CSIR-Central Drugs Research Institute (CDRI) here and evinced keen interest in the...
    AstraZeneca gets DCGI node for marketing asthma drug in India

    AstraZeneca gets DCGI node for marketing asthma drug in India

    Ruby Khatun Khatun21 Jun 2017 11:08 AM IST
    Mumbai: AstraZeneca has received the approval for marketing its asthma drug Symbicort Turbuhaler in India from Drug Controller General of India...
    High Court slaps Rs 5 lakh fine on Punjab Govt for ignoring Ranbaxy staff union plea

    High Court slaps Rs 5 lakh fine on Punjab Govt for ignoring Ranbaxy staff union plea

    Ruby Khatun Khatun20 Jun 2017 12:53 PM IST
    Chandigarh: The Punjab and Haryana high court has imposed fine of Rs 5 lakh to Punjab government for ignoring the plea of staff union of a...
    Rethink price cap on stents: US lawmakers ask India

    Rethink price cap on stents: US lawmakers ask India

    Ruby Khatun Khatun20 Jun 2017 10:56 AM IST
    New Delhi: A group of US lawmakers has backed medical device makers by urging India to reconsider its decision to cap prices of heart stents, raising...
    PrevNext

    Popular Stories

    India should become self-reliant in medical equipment, devices: Kasturirangan

    India should become self-reliant in medical equipment, devices: Kasturirangan

    Indian Genetics startup MedGenome raises Rs 415 crore in funding led by LeapFrog Investments

    Indian Genetics startup MedGenome raises Rs 415 crore in funding led by LeapFrog Investments

    GSK to fund doctoral programs at Government established Regional Centre for Biotechnology

    GSK to fund doctoral programs at Government established Regional Centre for Biotechnology

    Lupin gets USFDA EIR for Nagpur Facility

    Lupin gets USFDA EIR for Nagpur Facility

    CDSCO, Saudi Food and Drug Authority ink agreement for medical products regulations

    CDSCO, Saudi Food and Drug Authority ink agreement for medical products regulations

    AstraZeneca gets USFDA nod for Koselugo for paediatric patients with neurofibromatosis type 1

    AstraZeneca gets USFDA nod for Koselugo for paediatric patients with neurofibromatosis type 1

    Aurobindo Pharma gets USFDA nod for Fluoxetine Tablets

    Aurobindo Pharma gets USFDA nod for Fluoxetine Tablets

    SMS Pharma updates against USFDA statement on Ranitidine

    SMS Pharma updates against USFDA statement on Ranitidine

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok